Healthcare -
Biotechnology - NASDAQ - US
$ 0.84
-0.838 %
$ 65.7 M
Market Cap
5.25
P/E
CTMX - STOCK-BASED COMPENSATION
Stock-based Compensation CTMX - CytomX Therapeutics, Inc.
8.56 M
LAST VALUE
-19.38%
2 YEAR CAGR
-12.70%
5 YEAR CAGR
37.95%
10 YEAR CAGR